Compare JRSH & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JRSH | NSPR |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9M | 33.7M |
| IPO Year | 2017 | 2009 |
| Metric | JRSH | NSPR |
|---|---|---|
| Price | $4.68 | $0.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $4.00 | $4.00 |
| AVG Volume (30 Days) | ★ 87.3K | 65.8K |
| Earning Date | 02-09-2026 | 05-04-2026 |
| Dividend Yield | ★ 5.68% | N/A |
| EPS Growth | ★ 485.71 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $166,263,870.00 | $2,310,000.00 |
| Revenue This Year | $11.64 | $57.98 |
| Revenue Next Year | $10.06 | $95.41 |
| P/E Ratio | $17.26 | ★ N/A |
| Revenue Growth | ★ 14.03 | N/A |
| 52 Week Low | $2.85 | $0.63 |
| 52 Week High | $5.47 | $2.93 |
| Indicator | JRSH | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 56.63 | 37.17 |
| Support Level | $3.04 | $0.63 |
| Resistance Level | $4.86 | $0.72 |
| Average True Range (ATR) | 0.20 | 0.02 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 61.70 | 34.87 |
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.